Journal of Neuroscience, Vol 5, 1176-1179, Copyright © 1985 by Society for Neuroscience
Nerve growth factor treatment enhances nicotine-stimulated dopamine release and increases in cyclic adenosine 3':5'-monophosphate levels in PC12 cell cultures
L Baizer and N Weiner
In order to examine the relationship between cyclic AMP (cAMP) levels and
evoked neurotransmitter release, experiments have been performed with
cultures of clonal rat PC12 pheochromocytoma cells. Stimulation of the
release of endogenous dopamine by nicotine in these cultures is
calcium-dependent and blocked by d-tubocurarine, a specific nicotinic
cholinergic antagonist. Similarly, nicotine causes increases in cAMP levels
in PC12 cell cultures that are calcium-dependent and blocked by
d-tubocurarine. Cultures treated for 6 days or longer with 2 X 10(-9) M
nerve growth factor (NGF) release a 3- to 4-fold greater amount of dopamine
than do control cultures in response to a maximal concentration of
nicotine. Correspondingly, nicotine causes a 3-fold greater increase in
cAMP levels in the NGF-treated cultures than in the controls. These results
suggest that stimulation of the nicotinic cholinergic receptor in PC12
cells results in some manner in the activation of adenylate cyclase and
further support the notion that cAMP is involved in the process of
neurotransmitter release.